Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Ranking of carcinogenic potency using a relative potency approach

Abstract

Protocols for long-term carcinogen bioassays have become highly refined. The ability to interpret these bioassay results beyond the experimental setting, however, has not improved commensurately. As a consequence, society is still faced with the fact that data derived in these bioassays reflect highly specific experimental conditions which are vastly different from environmental exposures of the freely roaming, outbred human. The scientific community has responded with a “collective wisdom” approach by using expert committees to interpret bioassay evidence. This committee approach is believed to be successful in protecting human health, but the list of suspected carcinogens is growing faster than the expert committees can respond.

We have developed a relative potency framework for ranking the hazards represented by potential human carcinogens. The results demonstrate a rank ordering of a variety of compounds which is independent of the reference compound used to standardize the information. The philosophic basis of the approach may facilitate expert risk assessment systems development because it: (1) complements and supports “expert committee” data selection; (2) has a simple set of rules and does not require mathematical modeling; (3) requires no special situation judgments; and (4) is suitable for use with electronic data bases.

This is a preview of subscription content, log in to check access.

References

  1. Ames BN, Magaw R, Gold LS (1987) Ranking possible carcinogenic hazards. Science 236:271–280

  2. Anderson EL, The Carcinogen Assessment Group of the U.S. Environmental Protection Agency (1983) Quantitative approaches in use to assess cancer risk. Risk Anal 3(4):277–295

  3. Casarett AP (1968) Radiation biology. Prentice-Hall, Inc, Englewood Cliffs, NJ

  4. Clayson DB (1986) Toxicological risk assessment. In: Clayson DB, Krewski D, Munro I (eds) Biological and statistical criteria. Vol I, CRC Press, Inc, Boca Raton, FL, pp 105–122

  5. Clayson D, Krewski D, Munro IC (1983) The power and interpretation of the carcinogen bioassay. Reg Toxicol and Pharmacol 3:329–348

  6. Cothern CR, Coniglio WA, Marcus WL (1987) Uncertainty in population risk estimates for environmental contamination. In: Covello VT, Lave LB, Moghissi A, Uppuluri VRR (eds) Uncertainties in risk assessment, risk management, and decision making. Plenum Press, NY, pp 265–285

  7. Dudney CS, Walsh PJ, Jones TD, Calle EE, Griffin GD (1983) On the use of relative toxicity for risk estimation. In: Waters MD, Sandhu SS, Lewtas J, Chernoff D, Nesnow SN (eds) Short-term bioassays in the analysis of complex environmental mixtures. Vol III, Plenum Press, NY, pp 499–513

  8. Farber E (1984) Cellular biochemistry of the stepwise development of cancer with chemicals: G.H.A. Clowes Memorial Lecture. Cancer Res 44:5463–5474

  9. Flavin DF (1984) Toxicity, tumor promotion, and carcinogenesis in relation to excessive dosage. Regul Toxicol Pharmacol 4:372–379

  10. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE (1966) Quantitative comparison of toxicity of anti-cancer agents in the mouse, rat, hamster, dog monkey, and man. Cancer Chemother Rep 50:219–245

  11. Glass LR, Jones TD, Easterly CE, Walsh PJ (1991) Use of short-term test systems for the prediction of the hazard represented by potential chemical carcinogens. ORNL/TM-11413, Oak Ridge National Laboratory Report, Oak Ridge, TN

  12. Goldstein A, Aronow L, Kaiman SM (1974) Principles of drug action: The basis of pharmacology. John Wiley and Sons, NY

  13. Iball J (1939) The relative potency of carcinogenic compounds. Am J Cancer 35:188–190

  14. International Agency for Research on Cancer (1982) Chemicals, industrial processes, and industries associated with cancer in humans, IARC Monographs, Vols 1–29, In: IARC monographs on the evaluation of carcinogenic risk of chemicals to humans, Supplement 4, Lyon, France

  15. Jones TD, Griffin GD, Walsh PJ (1983) A unifying concept for carcinogenic risk assessments. J Theor Biol 105:35–61

  16. Jones TD, Walsh PJ, Watson AP, Owen BA, Barnthouse LW, Sanders DA (1988) Chemical scoring by a rapid screening of hazard (RASH) mimics decisions of expert committees. Risk Anal 8(1):99–118

  17. Jones TD, Walsh PJ (1985) Animal Studies and prediction of human tumors can be aided by graphical sorting of animal data: neo-plastic risk from B(a)P, benzene, benzidine and chromium. Am J Ind Med 7:185–217

  18. Jones TD, Trabalka FR, Owen BA, Walsh PJ, Barnthouse LW, Easterly CE (1991) Chemical pollutants: A caricaturized logos for future planning. Environmental Auditor (in press)

  19. Klaassen CD, Amdur MO, Doull J (eds) (1986) Casarett and Doull's toxicology: The basic science of poisons. Macmillan Publishing Co, NY

  20. Larner J (1980) Insulin and oral hypoglycemic drugs; glucagon. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacologic basis of therapeutics. Macmillan Publishing Co, NY

  21. Lewis RL, Sweet DV (1987) Registry of toxic effects of chemical substances data tape. National Institute for Occupational Safety and Health, U.S. Department of Health and Human Services, Cincinnati, OH

  22. McCann J, Ames BN (1977) The salmonella/microsome mutagenicity test: Predictive value for animal carcinogenicity. In: Hiatt HH, Watson JD, Watson JA (eds) Origins of human cancer. Cold Spring Harbor Conferences on Cell Proliferation. Cold Spring Harbor Laboratory, NY, pp 1431–1450

  23. National Toxicology Program (1984) Board of Scientific Counselors: Report of the NTPAd Hoc Panel on Chemical Carcinogenesis Testing and Evaluation

  24. Owen BA, Jones TD (1990) Hazard evaluation for complex mixtures: Relative comparisons to improve regulatory consistency. Reg Toxicol Pharmacol 11:132–148

  25. Purchase IHF (1980) Range of experimental evidence in assessing potential human risk. In: Quantitative aspects of risk assessment in chemical carcinogenesis. Arch Toxicol Suppl 3:283–293

  26. Roe FJC (1987) Opinions on animal selection for the assessment of carcinogenicity. In: Roloff MV, Wilson AGE, Ribelin WE, Ridley WP, Ruecker FA (eds) Human risk assessment — the role of animal selection and extrapolation. Taylor and Francis, NY, pp 31–44

  27. Shank RC, Barrows LR (1986) Toxicological effects on carcinogenesis. In: Clayson DB, Krewski D, Munro I (eds) Toxicological risk assessment, biological and statistical criteria, Vol I, CRC Press, Inc, Boca Raton, FL, pp 91–104

  28. Snedecor GW, Cochran WG (1982) Statistical Methods. The Iowa State University Press, Ames, IA

  29. Squire RA (1984) Carcinogenicity testing and safety assessment. Fund Appl Toxicol 4:S326-S334

  30. Steel RGD, Torrie JH (1980) Principles and procedures of statistics, A biometrical approach, McGraw-Hill Book Co, NY

  31. Task Force of Past Presidents of the Society of Toxicology (1982) Animal data in hazard evaluation: Paths and pitfalls. Fund Appl Toxicol 2:101–107

  32. Theiss JC (1986) The ranking of chemicals for carcinogenic hazards. Proceedings: New directions on the extrapolation of health risks from animals to man. Vol 1, Extrapolation from animals to man. EPRI EA-4447, Electric Power Research Institute, Palo Alto, CA

  33. Walsh PJ, Jones TD, Griffin GD, Dudney CS, Calle EE, Easterly CE (1982) Risk assessment approaches: general definitions, limitations and research needs. J Environ Sci Health A17(4):541–552

Download references

Author information

Correspondence to Clay E. Easterly.

Additional information

This research was supported in part by an appointment (Larry R. Glass) to the U.S. Department of Energy Laboratory Cooperative Postgraduate Research Program administered by Oak Ridge Associated Universities.

Managed by Martin Marietta Energy Systems, Inc., for the U.S. Department of Energy under contract DE-AC05-84OR21400.

“The submitted manuscript has been authored by a contractor of the U.S. Government under contract No. DE-AC05-84OR21400. Accordingly, the U.S. Government retains a nonexclusive, royalty-free license to publish or reproduce the published form of this contribution, or allow others to do so, for U.S. Government purposes”

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Glass, L.R., Easterly, C.E., Jones, T.D. et al. Ranking of carcinogenic potency using a relative potency approach. Arch. Environ. Contam. Toxicol. 21, 169–176 (1991). https://doi.org/10.1007/BF01055333

Download citation

Keywords

  • Risk Assessment
  • Relative Potency
  • Expert Committee
  • Human Carcinogen
  • Specific Experimental Condition